Focusfreda & CPHI China 2025 | Advancing Pharmaceutical Innovation with Medical-Grade Sodium Hyaluronate

Focusfreda is proud to join the global pharmaceutical community at CPHI China 2025, taking place from June 24–26 at the Shanghai New International Expo Centre (SNIEC). As part of the joint exhibition with the Freda Group, we invite you to visit our booth and discover our latest innovations in medical-grade Sodium Hyaluronate.

Leveraging our proprietary microbial fermentation platform and cutting-edge purification technologies, we offer a more full portfolio of pharma-grade Sodium Hyaluronate ingredients that meet more national standards. Our API grade Sodium Hyaluronate are registering in markets including China, South Korea, the EU, and India, with multiple DMF filings and custom formulation capabilities that support safety, efficacy, and compliance.

Whether you’re a pharmaceutical manufacturer, R&D specialist, or regulatory expert, we welcome you to connect with our expert team and explore how our solutions can support your innovation pipeline.

Find us at E2B02 – CPHI China 2025, SNIEC, Shanghai

Let’s shape the future of Sodium Hyaluronate pharmaceutical science, together.